|
|
|
|
||
Some changes.Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD (BETonMACE) https://clinicaltrials.gov/archive/NCT02586155/2016_07_21/changes https://clinicaltrials.gov/ct2/show/NCT02586155?term=resverlogix&rank=2 |
return to message board, top of board |